中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2010年
5期
576-578
,共3页
张莉%尹宁%张斯璧%蒋文旭
張莉%尹寧%張斯璧%蔣文旭
장리%윤저%장사벽%장문욱
胰蛋白酶抑制剂%肾功能试验%心肺转流术%婴儿
胰蛋白酶抑製劑%腎功能試驗%心肺轉流術%嬰兒
이단백매억제제%신공능시험%심폐전류술%영인
Trypsin inhibitors%Kidney function tests%Cardiopulmonary bypass%Infant
目的 评价乌司他丁对体外循环心内直视手术婴儿围术期肾功能的影响.方法 择期拟行心内直视手术的室间隔缺损伴肺动脉高压婴儿40例,月龄3~5月,体重5.3~6.8kg,ASA分级Ⅱ级,性别不限.随机分为2组(n=20):对照组(C组)和乌司他丁组(U组).U组将乌司他丁20 000 U/kg溶于20 ml生理盐水中,颈内静脉注射1/3量,体外循环开始时和主动脉开放即刻预充液中各充入1/3量;C组用生理盐水替代.分别于切皮前30 min(T1)、主动脉阻断前5 min(T2)、主动脉开放后5 min(T3)、术毕(T4)、术后24 h(T5)和48 h(T6)时,留取新鲜尿液,并采集颈内静脉血样,测定尿β2-微球蛋白(β2-MG)浓度和N-乙酞-β-D-葡萄糖苷酶(NAG)活性、血清Cr和BUN的浓度.结果 两组血清BUN和Cr浓度组内和组间比较差异无统计学意义(P>0.05).与T1时比较,两组T2-6时尿NAG活性和β2-MG浓度升高(P<0.05);与C组比较,U组T3-5时尿NAG活性和β2-MG浓度降低(P<0.05).结论 乌司他丁可保护体外循环心内直视手术婴儿围术期的肾功能.
目的 評價烏司他丁對體外循環心內直視手術嬰兒圍術期腎功能的影響.方法 擇期擬行心內直視手術的室間隔缺損伴肺動脈高壓嬰兒40例,月齡3~5月,體重5.3~6.8kg,ASA分級Ⅱ級,性彆不限.隨機分為2組(n=20):對照組(C組)和烏司他丁組(U組).U組將烏司他丁20 000 U/kg溶于20 ml生理鹽水中,頸內靜脈註射1/3量,體外循環開始時和主動脈開放即刻預充液中各充入1/3量;C組用生理鹽水替代.分彆于切皮前30 min(T1)、主動脈阻斷前5 min(T2)、主動脈開放後5 min(T3)、術畢(T4)、術後24 h(T5)和48 h(T6)時,留取新鮮尿液,併採集頸內靜脈血樣,測定尿β2-微毬蛋白(β2-MG)濃度和N-乙酞-β-D-葡萄糖苷酶(NAG)活性、血清Cr和BUN的濃度.結果 兩組血清BUN和Cr濃度組內和組間比較差異無統計學意義(P>0.05).與T1時比較,兩組T2-6時尿NAG活性和β2-MG濃度升高(P<0.05);與C組比較,U組T3-5時尿NAG活性和β2-MG濃度降低(P<0.05).結論 烏司他丁可保護體外循環心內直視手術嬰兒圍術期的腎功能.
목적 평개오사타정대체외순배심내직시수술영인위술기신공능적영향.방법 택기의행심내직시수술적실간격결손반폐동맥고압영인40례,월령3~5월,체중5.3~6.8kg,ASA분급Ⅱ급,성별불한.수궤분위2조(n=20):대조조(C조)화오사타정조(U조).U조장오사타정20 000 U/kg용우20 ml생리염수중,경내정맥주사1/3량,체외순배개시시화주동맥개방즉각예충액중각충입1/3량;C조용생리염수체대.분별우절피전30 min(T1)、주동맥조단전5 min(T2)、주동맥개방후5 min(T3)、술필(T4)、술후24 h(T5)화48 h(T6)시,류취신선뇨액,병채집경내정맥혈양,측정뇨β2-미구단백(β2-MG)농도화N-을태-β-D-포도당감매(NAG)활성、혈청Cr화BUN적농도.결과 량조혈청BUN화Cr농도조내화조간비교차이무통계학의의(P>0.05).여T1시비교,량조T2-6시뇨NAG활성화β2-MG농도승고(P<0.05);여C조비교,U조T3-5시뇨NAG활성화β2-MG농도강저(P<0.05).결론 오사타정가보호체외순배심내직시수술영인위술기적신공능.
Objective To investigate the effect of ulinastatin on the renal function during perioperative period in infants undergoing open heart surgery under CPB.Methods Forty ASA Ⅱ infants (25 male, 15 female)aged 3-5 months weighing 5.3-6.8 kg undergoing open heart surgery under CPB were randomly divided into 2 groups (n = 20 each): control group (group C) and ulinastatin group (group U). Ulinastatin 20 000 U/kg in normal saline 20 ml was infused iv in 3 parts (1/3 was infused via CVP line when the catheter was successfully placed in the internal jugular vein; 1/3 at the beginning of CPB and 1/3 at aortic unclamping). Blood and urine samples were collected at 30 min before incision ( T1 ), 5 min before aortic clamping (T2 ), 5 min after aortic unclamping (T3 ), at the end of operation (T4) and 24 and 48 h after operation (T5, T6 ) for determination of serum urea nitrogen (BUN) and creatinine (Cr) and urinary N-acetyl-β-D-glucosaminidase (NAG) and β2-microglubin (β2-MG) levels. Results There was no significant difference in serum BUN and Cr concentrations between the two groups. The urinary β2-MG concentration and NAG activity were significantly increased at T2-6 as compared with baseline values at T1 in both groups. The urinary β2-MG concentration and NAG activity were significantly lower in group U than in group C at T3-5 . Conclusion Ulinastatin can protect the renal function during perioperative period in infants undergoing open heart surgery under CPB.